S.Amdt. 447Senate118th Congress (2023-2025)
S.Amdt. 447
Sponsored by
Sen. Richard Blumenthal (D-CT)
Submitted July 13, 2023
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
July 13, 2023
View full timeline
Floor
Senate amendment submitted
July 13, 2023
Floor
Senate amendment submitted
July 13, 2023
Text
Submitted
SA 447. Mr. BLUMENTHAL submitted an amendment intended to be proposed by him to the bill S. 2226, to authorize appropriations for fiscal year 2024 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in title VII, insert the following: SEC. __. REPORT ON COVERAGE OF MIGRAINE PREVENTION AND TREATMENT DEVICES. (a) Findings.--Congress finds the following: (1) Members of the Armed Forces are diagnosed with or exhibit symptoms of migraines at a rate that is 3 times higher than the general population. (2) 1 in 3 members of the Armed Forces experience severe headaches and migraines within the first months after returning from deployment. (3) Women are 3 to 6 times more likely than men to experience migraines. (4) Operational barriers, performance-limiting adverse effects, and the ineffectiveness of drug treatments for some members of the Armed Forces demonstrate the necessity of increasing the availability of non-pharmacological devices that can treat and prevent migraines. (b) Report.--Not later than 120 days after the date of the enactment of this Act, the Secretary of Defense shall submit to Congress a report on the plan of the Secretary to provide non-pharmacological, neuromodulation migraine prevention and treatment devices that have been cleared by the Food and Drug Administration to members of the Armed Forces who could benefit from those devices. ______